Potential use of 2-hydroxypropyl-β-cyclodextrin for preparation of orally disintegrating tablets containing dl-α-tocopheryl acetate, an oily drug
-
- Motoyama Keiichi
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Nagatomo Kiyoshi
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Elazim Soliman Osama Abd
- Graduate School of Pharmaceutical Sciences, Kumamoto University
-
- Hirayama Fumitoshi
- Faculty of Pharmaceutical Sciences, Sojo University
-
- Uekama Kaneto
- Faculty of Pharmaceutical Sciences, Sojo University
-
- Arima Hidetoshi
- Graduate School of Pharmaceutical Sciences, Kumamoto University
書誌事項
- タイトル別名
-
- Potential Use of 2-Hydroxypropyl-.BETA.-cyclodextrin for Preparation of Orally Disintegrating Tablets Containing dl-.ALPHA.-Tocopheryl Acetate, an Oily Drug
- Potential use of 2 hydroxypropyl v cyclodextrin for preparation of orally disintegrating tablets containing dl a tocopheryl acetate an oily drug
この論文をさがす
抄録
To expand the application of a drug in orally disintegrating tablets, the potential use of β-cyclodextrin (β-CyD) and 2-hydroxypropyl-β-cyclodextrin (HP-β-CyD) as excipients for the tablets containing dl-α-tocopheryl acetate (VE), an oily drug, was evaluated. HP-β-CyD, not β-CyD, solubilized VE in water through the formation of higher order of complexes at the molar ratio of 1 : 2 (VE : HP-β-CyD). When prepared under the optimal preparation conditions, the VE tablets containing lactose and 5% (w/w) of HP-β-CyD, not β-CyD, had high hardness more than 4 kg and rapid disintegration within 100 s both in vitro and in vivo. In addition, VE tablets containing lactose and 5% (w/w) of HP-β-CyD, not β-CyD, maintained the high hardness and rapid disintegration under the accelerated stability test using different conditions for 4 weeks. Therefore, these results suggest the potential use of HP-β-CyD, not β-CyD, as an excipient for orally disintegrating tablets containing VE, an oily drug, in the molding method.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 57 (11), 1206-1212, 2009
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679146136704
-
- NII論文ID
- 130000124809
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 10412421
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可